The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. (EFFECT)
Sponsor: The University of The West Indies
A PHASE2/PHASE3 clinical study on Platelet Dysfunction Due to Drugs, this trial is completed. The trial is conducted by The University of The West Indies and has accumulated 8 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Oct 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Sep 2023 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Status: Unknown Status → Completed
▶ Show 3 earlier versions
-
May 2022 — Sep 2023 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
-
Jan 2021 — May 2022 [monthly]
Recruiting PHASE2_PHASE3
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of The West Indies
For direct contact, visit the study record on ClinicalTrials.gov .